ChiCTR2100042437 版本V1.1 版本创建时间2021/04/25 01:34:15 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2100042437 

最近更新日期:

Date of Last Refreshed on:

2021-04-25 01:33:07 

注册时间:

Date of Registration:

2021-01-21 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

请于伦理委员会批准后才开始征募参试者,并与我们联系上传伦理批件。 应用持续葡萄糖监测评估血糖波动对急诊多发伤患者预后影响的探索性研究

Public title:

The effect of glucose fluctuation on the prognosis of patients with emergency multiple injuries by using the continuous glucose monitoring system: an exploratory study

注册题目简写:

English Acronym:

研究课题的正式科学名称:

应用持续葡萄糖监测评估血糖波动对急诊多发伤患者预后影响的探索性研究

Scientific title:

The effect of glucose fluctuation on the prognosis of patients with emergency multiple injuries by using the continuous glucose monitoring system: an exploratory study

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

贺星星 

研究负责人:

贺星星 

Applicant:

Xingxing He 

Study leader:

Xingxing He 

申请注册联系人电话:

Applicant telephone:

+86 15800596153

研究负责人电话:

Study leader's
telephone:

+86 15800596153

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

1536943187@qq.com

研究负责人电子邮件:

Study leader's E-mail:

1536943187@qq.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

上海市徐汇区宜山路600号

研究负责人通讯地址:

上海市徐汇区宜山路600号

Applicant address:

600 Yishan Road, Shanghai, China

Study leader's address:

600 Yishan Road, Shanghai, China

申请注册联系人邮政编码:

Applicant postcode:

200233

研究负责人邮政编码:

Study leader's postcode:

200233

申请人所在单位:

上海交通大学附属第六人民医院

Applicant's institution:

Shanghai Jiao Tong University Affiliated Sixth People’s Hospital

研究负责人所在单位:

上海交通大学附属第六人民医院

Affiliation of the Leader:

Shanghai Jiao Tong University Affiliated Sixth People’s Hospital

是否获伦理委员会批准:

Approved by ethic committee:

No

伦理委员会批件文号:

Approved No. of ethic committee:

伦理委员会批件附件:

Approved file of Ethical Committee:

批准本研究的伦理委员会名称:

Name of the ethic committee:

伦理委员会批准日期:

Date of approved by ethic committee:

2013-08-26 00:00:00

伦理委员会联系人:

Contact Name of the ethic committee:

伦理委员会联系地址:

Contact Address of the ethic committee:

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

上海交通大学附属第六人民医院

Primary sponsor:

Shanghai Jiao Tong University Affiliated Sixth People's Hospital

研究实施负责(组长)单位地址:

上海市徐汇区宜山路600号

Primary sponsor's address:

600 Yishan Road, Shanghai, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

上海

市(区县):

Country:

China

Province:

Shanghai

City:

单位(医院):

上海交通大学附属第六人民医院

具体地址:

徐汇区宜山路600号

Institution
hospital:

Shanghai Jiao Tong University Affiliated Sixth People's Hospital

Address:

600 Yishan Road, Xuhui District

经费或物资来源:

上海交通大学附属第六人民医院

Source(s) of funding:

Shanghai Jiao Tong University Affiliated Sixth People’s Hospital

研究疾病:

急诊多发伤  

Target disease:

emergency multiple injuries

研究疾病代码:

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

连续入组 

Study design:

Sequential 

研究目的:

本研究通过应用瞬感扫描式持续葡萄糖监测系统,旨在明确多发伤合并糖尿病或非糖尿病患者发生急性创伤后的血糖波动情况,并评估血糖波动与多发伤患者创伤后并发症及预后的关系。  

Objectives of Study:

This study by applying intermittently scanned continuous glucose monitoring, aims to explore the blood glucose fluctuations after acute trauma in emergency multiple trauma patients with or without diabetes, and to evaluate the relationship between blood glucose fluctuation and post-traumatic complications and prognosis in patients with multiple injuries.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

年龄在18~75岁;
体质指数18.5~30kg/m2;
存在身体两处或两处以上解剖部位或脏器的创伤,其中至少有一处损伤可危及生命;创伤严重程度>16分。

Inclusion criteria

Aged 18 to 75 years old;
Body mass index 18.5 ~ 30kg/m2;
Two or more anatomical or visceral injuries in the body, at least one of which can be life-threatening; and the trauma severity score was >16 points.

排除标准:

颅脑创伤;
脊髓损伤;
妊娠糖尿病及其他特殊类型糖尿病;
入院前即存在严重肝脏或肾脏疾病;
入院前即存在严重的心脑血管疾病;
合并使用影响糖代谢的药物如糖皮质激素、甲状腺素等;
恶性肿瘤病史;
精神疾病病史;
孕妇及哺乳期妇女。

Exclusion criteria:

Traumatic brain injury;
Spinal cord injury;
Gestational diabetes and other special types of diabetes;
Severe liver or kidney disease prior to admission;
Severe cardiovascular and cerebrovascular diseases existed before admission;
Combined use of drugs that affect glucose metabolism, such as glucocorticoid, thyroxine, etc.
History of malignant tumor;
History of mental illness;
Pregnant and lactating women.

研究实施时间:

Study execute time:

From 2021-01-01 00:00:00 To 2023-12-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2021-01-21 00:00:00 To 2023-12-31 00:00:00

干预措施:

Interventions:

组别:

多发伤合并糖尿病组

样本量:

50

Group:

multiple trauma patients with diabetes group

Sample size:

干预措施:

干预措施代码:

Intervention:

Nil

Intervention code:

组别:

多发伤合并非糖尿病组

样本量:

50

Group:

multiple trauma patients without diabetes group

Sample size:

干预措施:

干预措施代码:

Intervention:

Nil

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

上海 

市(区县):

 

Country:

China

Province:

Shanghai

City:

单位(医院):

上海交通大学附属第六人民医院 

单位级别:

三甲 

Institution
hospital:

Shanghai Jiao Tong University Affiliated Sixth People's Hospital

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

血糖波动

指标类型:

主要指标

Outcome:

glucose fluctuation

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

任何部位的感染

指标类型:

主要指标

Outcome:

any infection

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

急性心血管事件

指标类型:

主要指标

Outcome:

Acute cardiovascular events

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

急性肾功能衰竭

指标类型:

主要指标

Outcome:

acute renal failure

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

计划外的气管插管

指标类型:

主要指标

Outcome:

Unplanned endotracheal intubation

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

住院时间

指标类型:

次要指标

Outcome:

length of stay

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

静脉血栓栓塞

指标类型:

主要指标

Outcome:

venous thromboembolism

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

气管插管时间

指标类型:

次要指标

Outcome:

Tracheal intubation time

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

血液

组织:

Sample Name:

blood

Tissue:

人体标本去向

使用后保存  

说明

Fate of sample:

Preservation after use  

Note:

标本中文名:

尿液

组织:

Sample Name:

urine

Tissue:

人体标本去向

使用后保存  

说明

Fate of sample:

Preservation after use  

Note:

征募研究对象情况:

Recruiting status:

正在进行

Recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 75 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

Randomization Procedure (please state who generates the random number sequence and by what method):

None

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

Blinding:

是否共享原始数据:

IPD sharing

是Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

如有需要,可联系邮箱1536943187@qq.com

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

The data can be obtained by contacting email 1536943187@qq.com.

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

数据采集:病例记录表; 数据管理:电子采集和管理系统

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Data collection: Case Record Form; Data management: Electronic Data Capture

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2021-01-21 12:58:22